SCHEMBL22177369

SCHEMBL22177369

c1ccc(-c2ccc(-c3cc(-c4cccc5sc6c(-c7nc8ccccc8s7)cccc6c45)nc(-c4ccccc4)n3)cc2)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 8/20 0.41
▸ MEN1 O00255 8/20 0.41
▸ KMT2A Q03164 8/20 0.41
▸ RAB9A P51151 7/20 0.41
▸ KDM4E B2RXH2 7/20 0.41
▸ ALDH1A1 P00352 7/20 0.41
▸ NPC1 O15118 5/20 0.41
▸ SMN1; SMN2 Q16637 4/20 0.41
▸ NFKB1 P19838 3/20 0.41
▸ NFKB2 Q00653 3/20 0.41
▸ RELA Q04206 3/20 0.41
▸ LMNA P02545 3/20 0.41
▸ POLB P06746 2/20 0.41
▸ TP53 P04637 1/20 0.41
▸ HSD17B10 Q99714 1/20 0.41
▸ GAA P10253 3/20 0.41
▸ TDP1 Q9NUW8 2/20 0.41
▸ L3MBTL1 Q9Y468 1/20 0.41
▸ NPSR1 Q6W5P4 1/20 0.39
▸ APP P05067 3/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22177368 0.98 RAB9A (0.43) MAPTMEN1KMT2ARAB9AKDM4E
SCHEMBL22178180 0.96 RAB9A (0.40) MAPTMEN1KMT2ARAB9AKDM4E
SCHEMBL22178179 0.94 RAB9A (0.41) MAPTMEN1KMT2ARAB9AKDM4E
SCHEMBL22177373 0.93 RAB9A (0.43) MAPTMEN1KMT2ARAB9AKDM4E
SCHEMBL22177372 0.91 RAB9A (0.45) MAPTMEN1KMT2ARAB9AKDM4E
SCHEMBL22177366 0.90 RAB9A (0.41) MAPTMEN1KMT2ARAB9AKDM4E
SCHEMBL22178073 0.90 RAB9A (0.44) MAPTMEN1KMT2ARAB9AKDM4E
SCHEMBL22178117 0.90 RAB9A (0.44) MAPTMEN1KMT2ARAB9AKDM4E
SCHEMBL22178412 0.90 RAB9A (0.46) MAPTMEN1KMT2ARAB9AKDM4E
SCHEMBL22700198 0.90 MEN1 (0.44) MAPTMEN1KMT2AKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11518769-B2 Heterocyclic compounds and organic light emitting device using the same LG CHEM, LTD. (KR) 2022-12-06 — — US disclosed
US-20200207754-A1 NOVEL HETEROCYCLIC COMPOUNDS AND ORGANIC LIGHT EMITTING DEVICE USING THE SAME LG CHEM, LTD. (KR) 2020-07-02 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200207754-A1 NOVEL HETEROCYCLIC COMPOUNDS AND ORGANIC LIGHT EMITTING DEVICE USING THE SAME CRY1, CRY2, CYP1A1 MAPT 1997/4885MEN1 344/4885KMT2A 884/4885
US-11518769-B2 Heterocyclic compounds and organic light emitting device using the same CRY1, CYP1A1, CRY2 MAPT 1660/4885MEN1 342/4885KMT2A 1637/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback